Matt Killeen

Company: Renovacor

Job title: Chief Scientific Officer

Seminars:

Developing Cell & Gene Therapies in Cardiovascular Disease to Transform the Treatment of Highly Medicated & Costly Conditions 12:30 pm

Join this interactive deep dive to unlock the potential of cell and gene therapies in altering the genetic material of patients’ cells, and provide hypertrophic cardiomyopathy (HCM) patients at risk of developing HFpEF valuable therapies to unlocking new phenotypes in both patient populations. Session highlights include: Identifying specific problems using precise, gene therapy approaches to…Read more

day: Pre-Conference Day PM